FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039336073> ?p ?o ?g. }

• W2039336073 endingPage "30" @default.
• W2039336073 startingPage "22" @default.
• W2039336073 abstract "BACKGROUND The authors showed previously that radiolabeled monoclonal antibody (MoAb) and a hand-held, gamma-detecting probe can be used to localize tumor-reactive lymph nodes in vivo. The authors examined the feasibility, safety, and biologic effects of cellular immunotherapy using autologous cells expanded from these lymph nodes in patients with metastatic colorectal carcinoma. METHODS Tumor-reactive lymph nodes containing radiolabeled MoAb were localized and excised from 32 patients with metastatic, unresectable colorectal carcinoma at laparotomy. Lymph nodes were dissociated, and cells were cultured ex vivo for 10–14 days. Patients received a single infusion of autologous, expanded cells with no systemic interleukin (IL)-2. RESULTS A mean of 1.6 × 1010 expanded autologous lymph node cells were infused with toxicity limited to occasional fevers or chills. The cells infused predominately were activated CD3+ T-cells that expressed genes for IL-4, IL-5, interferon-γ, and granulocyte-macrophage colony stimulating factor (GM-CSF) by using reverse transcriptase-polymerase chain reaction. Indium-111 labeled cells were observed to traffic initially to the lungs, bone marrow, liver, and spleen. One patient on study achieved a partial response (>80% reduction), and mixed or minor responses were noted in 4 other patients. The responding patient's cell characteristics were notable for high levels of GM-CSF and IL-4 secretion on restimulation with immobilized anti-CD3 in vitro, and biopsies of the tumor were characterized by macrophage infiltration. The median survival of the cell-treated group compared favorably with a similar group of patients who underwent radioimmunoguided surgery without cell treatment (12.5 months vs. 5.8 months) CONCLUSIONS The infusion of cells expanded from tumor-reactive lymph nodes localized with radiolabeled MoAb in vivo is reproducible and safe and has biologic activity, even in the absence of systemic IL-2 infusion. This approach represents a novel application of MoAb technology, in that MoAbs are used not to diagnose or treat disease directly but rather to identify lymph node cells with therapeutic potential. Cancer 1999;86:22–30. © 1999 American Cancer Society." @default.
• W2039336073 created "2016-06-24" @default.
• W2039336073 creator A5036803403 @default.
• W2039336073 creator A5041620748 @default.
• W2039336073 creator A5062878186 @default.
• W2039336073 creator A5081394849 @default.
• W2039336073 creator A5083008292 @default.
• W2039336073 creator A5087285442 @default.
• W2039336073 date "1999-07-01" @default.
• W2039336073 modified "2023-10-14" @default.
• W2039336073 title "Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody" @default.
• W2039336073 cites W1610398404 @default.
• W2039336073 cites W181158363 @default.
• W2039336073 cites W1966320652 @default.
• W2039336073 cites W1975777455 @default.
• W2039336073 cites W1977305815 @default.
• W2039336073 cites W1979780188 @default.
• W2039336073 cites W1991148746 @default.
• W2039336073 cites W1992421431 @default.
• W2039336073 cites W2001982394 @default.
• W2039336073 cites W2013411992 @default.
• W2039336073 cites W2022771239 @default.
• W2039336073 cites W2025581986 @default.
• W2039336073 cites W2040868302 @default.
• W2039336073 cites W2043536848 @default.
• W2039336073 cites W2080287537 @default.
• W2039336073 cites W2081605133 @default.
• W2039336073 cites W2087833524 @default.
• W2039336073 cites W2105998729 @default.
• W2039336073 cites W2143381422 @default.
• W2039336073 cites W2257968979 @default.
• W2039336073 cites W2261945645 @default.
• W2039336073 cites W2327121363 @default.
• W2039336073 cites W2341601510 @default.
• W2039336073 doi "https://doi.org/10.1002/(sici)1097-0142(19990701)86:1<22::aid-cncr5>3.0.co;2-t" @default.
• W2039336073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10391559" @default.
• W2039336073 hasPublicationYear "1999" @default.
• W2039336073 type Work @default.
• W2039336073 sameAs 2039336073 @default.
• W2039336073 citedByCount "17" @default.
• W2039336073 countsByYear W20393360732012 @default.
• W2039336073 countsByYear W20393360732013 @default.
• W2039336073 countsByYear W20393360732015 @default.
• W2039336073 countsByYear W20393360732016 @default.
• W2039336073 countsByYear W20393360732018 @default.
• W2039336073 countsByYear W20393360732020 @default.
• W2039336073 crossrefType "journal-article" @default.
• W2039336073 hasAuthorship W2039336073A5036803403 @default.
• W2039336073 hasAuthorship W2039336073A5041620748 @default.
• W2039336073 hasAuthorship W2039336073A5062878186 @default.
• W2039336073 hasAuthorship W2039336073A5081394849 @default.
• W2039336073 hasAuthorship W2039336073A5083008292 @default.
• W2039336073 hasAuthorship W2039336073A5087285442 @default.
• W2039336073 hasBestOaLocation W20393360731 @default.
• W2039336073 hasConcept C121608353 @default.
• W2039336073 hasConcept C126322002 @default.
• W2039336073 hasConcept C142724271 @default.
• W2039336073 hasConcept C150903083 @default.
• W2039336073 hasConcept C159654299 @default.
• W2039336073 hasConcept C203014093 @default.
• W2039336073 hasConcept C207001950 @default.
• W2039336073 hasConcept C26291073 @default.
• W2039336073 hasConcept C2777701055 @default.
• W2039336073 hasConcept C2779720271 @default.
• W2039336073 hasConcept C2780007613 @default.
• W2039336073 hasConcept C2780849966 @default.
• W2039336073 hasConcept C502942594 @default.
• W2039336073 hasConcept C542903549 @default.
• W2039336073 hasConcept C71924100 @default.
• W2039336073 hasConcept C86803240 @default.
• W2039336073 hasConceptScore W2039336073C121608353 @default.
• W2039336073 hasConceptScore W2039336073C126322002 @default.
• W2039336073 hasConceptScore W2039336073C142724271 @default.
• W2039336073 hasConceptScore W2039336073C150903083 @default.
• W2039336073 hasConceptScore W2039336073C159654299 @default.
• W2039336073 hasConceptScore W2039336073C203014093 @default.
• W2039336073 hasConceptScore W2039336073C207001950 @default.
• W2039336073 hasConceptScore W2039336073C26291073 @default.
• W2039336073 hasConceptScore W2039336073C2777701055 @default.
• W2039336073 hasConceptScore W2039336073C2779720271 @default.
• W2039336073 hasConceptScore W2039336073C2780007613 @default.
• W2039336073 hasConceptScore W2039336073C2780849966 @default.
• W2039336073 hasConceptScore W2039336073C502942594 @default.
• W2039336073 hasConceptScore W2039336073C542903549 @default.
• W2039336073 hasConceptScore W2039336073C71924100 @default.
• W2039336073 hasConceptScore W2039336073C86803240 @default.
• W2039336073 hasIssue "1" @default.
• W2039336073 hasLocation W20393360731 @default.
• W2039336073 hasLocation W20393360732 @default.
• W2039336073 hasOpenAccess W2039336073 @default.
• W2039336073 hasPrimaryLocation W20393360731 @default.
• W2039336073 hasRelatedWork W1940821735 @default.
• W2039336073 hasRelatedWork W1969289591 @default.
• W2039336073 hasRelatedWork W1971628265 @default.
• W2039336073 hasRelatedWork W1972952460 @default.
• W2039336073 hasRelatedWork W1974589218 @default.
• W2039336073 hasRelatedWork W2067193714 @default.
• W2039336073 hasRelatedWork W2159193724 @default.

• next